The future of the brain. In it we cover digital therapies, psychedelics, co-evolving with AI, technologies impact on society, and re-inventing how clinical trials are run.

Guiding us will be Dr Adam Gazzaley, a Distinguished Professor of Neurology, Physiology and Psychiatry at UC San Francisco and the Founder & Executive Director of Neuroscape, a neuroscience center engaged in technology creation and scientific research of novel brain assessment and optimization approaches. Adam is also co-founder of Akili, a company developing therapeutic video games, that brought the first FDA approved game to market. He is also a founder of JAZZ Venture Partners, a venture capital firm with close to $1B AUM investing in experiential technology to improve human performance. He has been a scientific advisor for dozens of companies including Apple, General Electric and PepsiCo. Adam has filed multiple patents and authored over 180 scientific articles.

Subscribe for the latest episodes. Email me on danieldarling@focal.vc

The future of the brain. In it we cover digital therapies, psychedelics, co-evolving with AI, technologies impact on society, and re-inventing how clinical trials are run.
Guiding us will be Dr Adam Gazzaley, a Distinguished Professor of Neurology, Physiology and Psychiatry at UC San Francisco and the Founder &amp; Executive Director of Neuroscape, a neuroscience center engaged in technology creation and scientific research of novel brain assessment and optimization approaches. Adam is also co-founder of Akili, a company developing therapeutic video games, that brought the first FDA approved game to market. He is also a founder of JAZZ Venture Partners, a venture capital firm with close to $1B AUM investing in experiential technology to improve human performance. He has been a scientific advisor for dozens of companies including Apple, General Electric and PepsiCo. Adam has filed multiple patents and authored over 180 scientific articles.
Subscribe for the latest episodes. Email me on <a href="mailto:danieldarling@focal.vc">danieldarling@focal.vc</a>

Fast forward 5 years to view the future of an industry through the eyes of its most innovative entrepreneurs and CEOs.

Learn what key industries could look like in 5 years.

Witness the evolution through the eyes of leading CEOs.

Discover who gets disrupted and who wins big.

Hear of mind blowing technology set to reinvent all the rules.

Reshape your mental model to thrive in the change ahead.

Delivered as short (~30 mins), insight-packed discussions, that will spark imagination and leave listeners with a preview of what lies ahead.

Fast forward 5 years to view the future of an industry through the eyes of its most innovative entrepreneurs and CEOs.
Learn what key industries could look like in 5 years.
Witness the evolution through the eyes of leading CEOs.
Discover who gets disrupted and who wins big.
Hear of mind blowing technology set to reinvent all the rules.
Reshape your mental model to thrive in the change ahead.
Delivered as short (~30 mins), insight-packed discussions, that will spark imagination and leave listeners with a preview of what lies ahead.

5 Year Frontier

#19: Turbocharging the mind, digital drugs, psychedelics, autonomous therapies, the neuroscience frontier, and the future of the brain w/ Neuroscape Founder Dr Adam Gazzaley

The future of biology. In it we cover machines controlling cells, manipulating biology with light, algorithms for drug development, and how biotech is becoming a low cost and mass production industry.

Deniz Kent is CEO of Prolific Machines. Prolific is the first biotech company to harness light as a more efficient way to produce lab grown food, life saving drugs, and novel biosolutions. Offering a full stack tool kit from bioreactor to AI-software, Prolific’s groundbreaking technology provides dynamic control over virtually any cell function in any cell type. Until now, biomanufacturing has been limited to indirect cell control via expensive, inefficient, and imprecise tools like chemicals. Prolific’s platform enables direct control using light to produce new and superior biolsolutions faster, cheaper, and at greater scale. Based in Silicon Valley, the four year old company has raised $87 million in venture capital from the likes of Mayfield, Breakthrough Energy Ventures, In-Q-Tel and Fonterra. Prolific’s co-founder and CEO is Dr Deniz Kent, an expert in biological systems who earned his PhD in the Center for Stem Cells and Regenerative Medicine at King’s College London. During his studies he co-discovered a new human liver stem cell, worked on cures for Asthma at GlaxoSmithKline and develop research in the field of cancer immunotherapy.

Sign up for new podcasts and our newsletter, and email me on danieldarling@focal.vc

The future of biology. In it we cover machines controlling cells, manipulating biology with light, algorithms for drug development, and how biotech is becoming a low cost and mass production industry.
Deniz Kent is CEO of Prolific Machines. Prolific is the first biotech company to harness light as a more efficient way to produce lab grown food, life saving drugs, and novel biosolutions. Offering a full stack tool kit from bioreactor to AI-software, Prolific’s groundbreaking technology provides dynamic control over virtually any cell function in any cell type. Until now, biomanufacturing has been limited to indirect cell control via expensive, inefficient, and imprecise tools like chemicals. Prolific’s platform enables direct control using light to produce new and superior biolsolutions faster, cheaper, and at greater scale. Based in Silicon Valley, the four year old company has raised $87 million in venture capital from the likes of Mayfield, Breakthrough Energy Ventures, In-Q-Tel and Fonterra. Prolific’s co-founder and CEO is Dr Deniz Kent, an expert in biological systems who earned his PhD in the Center for Stem Cells and Regenerative Medicine at King’s College London. During his studies he co-discovered a new human liver stem cell, worked on cures for Asthma at GlaxoSmithKline and develop research in the field of cancer immunotherapy.
<a href="http://podfollow.com/5-year-frontier" data-saferedirecturl="https://www.google.com/url?q=http://podfollow.com/5-year-frontier&amp;source=gmail&amp;ust=1729913572103000&amp;usg=AOvVaw3gvSs6IxZGMcAlM3LoO9LG">Sign up</a> for new podcasts and <a href="https://www.5yearfrontier.focal.vc/" data-saferedirecturl="https://www.google.com/url?q=https://www.5yearfrontier.focal.vc/&amp;source=gmail&amp;ust=1729913572103000&amp;usg=AOvVaw2r823bBwlLVvPAm_rBpcdT">our newsletter</a>, and email me on <a href="mailto:danieldarling@focal.vc">danieldarling@focal.vc</a>

#26: Machines Controlling Biology, Light Reprogramming Cells, Algorithms for Drug Development, Commoditizing Pharma, and the Future of Biotechnology w/ Prolific Machines CEO Deniz Kent

The future of cybersecurity. In it we cover cybercriminal organizations, network effects of security, data as our biggest weapon, crypto’s gift to bad actors and the threat of cyberwarfare.

Nick Schneider is CEO of Arctic Wolf, one of the leading companies safeguarding the enterprise from cybersecurity threats. With a global presence and over 2,000 employees protecting more than 3,000 customers, they are a force in security operations. With an eye on going public, Arctic Wolf has been valued at over $4B calling KKR and Viking Global amongst its deep pocketed investors. Leading the company is Nick Schneider, a veteran in the security industry, Nick has developed expertise in creating best-of-breed technology platforms and sales organizations, which have been the driving force behind Arctic Wolf’s explosive growth. Prior to Arctic Wolf, Nick led organizations at Dell and Code42.

Of key interest to me is how Nick is deeply involved in being at the frontier of artificial intelligence’s influence on cybersecurity — in particulate the dual role of AI, as both an enabler and inhibitor of cybercrime, which epitomizes the modern cybersecurity conundrum.


Sign up for new podcasts and our newsletter, and email me on danieldarling@focal.vc

The future of cybersecurity. In it we cover cybercriminal organizations, network effects of security, data as our biggest weapon, crypto’s gift to bad actors and the threat of cyberwarfare.
Nick Schneider is CEO of Arctic Wolf, one of the leading companies safeguarding the enterprise from cybersecurity threats. With a global presence and over 2,000 employees protecting more than 3,000 customers, they are a force in security operations. With an eye on going public, Arctic Wolf has been valued at over $4B calling KKR and Viking Global amongst its deep pocketed investors. Leading the company is Nick Schneider, a veteran in the security industry, Nick has developed expertise in creating best-of-breed technology platforms and sales organizations, which have been the driving force behind Arctic Wolf’s explosive growth. Prior to Arctic Wolf, Nick led organizations at Dell and Code42.
Of key interest to me is how Nick is deeply involved in being at the frontier of artificial intelligence’s influence on cybersecurity — in particulate the dual role of AI, as both an enabler and inhibitor of cybercrime, which epitomizes the modern cybersecurity conundrum.
 <a href="http://podfollow.com/5-year-frontier" data-saferedirecturl="https://www.google.com/url?q=http://podfollow.com/5-year-frontier&amp;source=gmail&amp;ust=1729028295779000&amp;usg=AOvVaw1z02N1WKPzkd7uVh5HQHkp">Sign up</a> for new podcasts and <a href="https://www.5yearfrontier.focal.vc/" data-saferedirecturl="https://www.google.com/url?q=https://www.5yearfrontier.focal.vc/&amp;source=gmail&amp;ust=1729028295779000&amp;usg=AOvVaw1TYJV3PoRYt-8K-YlcWa4I">our newsletter</a>, and email me on <a href="mailto:danieldarling@focal.vc">danieldarling@focal.vc</a>

 #25: Cyber Attacks, AI Criminals, Deep Fakes, Data Shields, and the Future of Cybersecurity w/ Arctic Wolf CEO Nick Schneider

The future of biomanufacturing. In it we cover the emerging $4T bioeconomy, nature’s ability to manufacture products, AI’s acceleration of scientific discovery, China’s quest for biological supremacy, and rethinking sustainability.

Edward Shenderovich is CEO of Synonym, prior he was both an investor and entrepreneur, founding commercial real estate company Knotel where he raised over $400M and managed 200 locations across 4 continents. As an investor he founded Kite Ventures as well as Essential Capital, which include Delivery Hero and Fyber as their investments, both reaching IPO. Uniquely, Edward is also an accomplished Poet, having published multiple books in his native Russian.

Sign up for new podcasts and our newsletter, and email me on danieldarling@focal.vc

The future of biomanufacturing. In it we cover the emerging $4T bioeconomy, nature’s ability to manufacture products, AI’s acceleration of scientific discovery, China’s quest for biological supremacy, and rethinking sustainability.
Edward Shenderovich is CEO of Synonym, prior he was both an investor and entrepreneur, founding commercial real estate company Knotel where he raised over $400M and managed 200 locations across 4 continents. As an investor he founded Kite Ventures as well as Essential Capital, which include Delivery Hero and Fyber as their investments, both reaching IPO. Uniquely, Edward is also an accomplished Poet, having published multiple books in his native Russian.
<a href="http://podfollow.com/5-year-frontier" data-saferedirecturl="https://www.google.com/url?q=http://podfollow.com/5-year-frontier&amp;source=gmail&amp;ust=1727439172724000&amp;usg=AOvVaw3uF9NOs6GX95gSGMdN6TA9">Sign up</a> for new podcasts and <a href="https://www.5yearfrontier.focal.vc/" data-saferedirecturl="https://www.google.com/url?q=https://www.5yearfrontier.focal.vc/&amp;source=gmail&amp;ust=1727439172724000&amp;usg=AOvVaw1uWA9N_b8dmRKZG78ovJm2">our newsletter</a>, and email me on <a href="mailto:danieldarling@focal.vc">danieldarling@focal.vc</a>

#19: Turbocharging the mind, digital drugs, psychedelics, autonomous therapies, the neuroscience frontier, and the future of the brain w/ Neuroscape Founder Dr Adam Gazzaley

5 Year Frontier

In 1 playlist(s)

5 Year Frontier

Social links

Follow podcast

Recent clips